Sex, health, and athletes

  title={Sex, health, and athletes},
  author={Rebecca M. Jordan-Young and Peter S{\"o}nksen and Katrina Karkazis},
  journal={BMJ : British Medical Journal},
Recent policy introduced by the International Olympic Committee to regulate hyperandrogenism in female athletes could lead to unnecessary treatment and may be unethical, argue Rebecca Jordan-Young, Peter Sönksen, and Katrina Karkazis 

Coercing women athletes with high androgen levels into medical interventions

As director of the only legal agency in the US focused on serving children and youth with differences of sex development or intersex conditions, the international sports authorities’ response to concerns about gender identity is commendable.

Sex, gender, and sports

New regulations challenge the evidence based, benevolent ethos that underlies medical practice and are likely to have an impact on patient safety and quality.

Sex testing in sport can ruin lives

  • P. Sperryn
  • Education
    BMJ : British Medical Journal
  • 2014
As a former doctor to international teams, I realised that sex testing had the potential to be unscientific, inhumane, and a sign of sex bias.

Caster Semenya, athlete classification, and fair equality of opportunity in sport

  • S. Loland
  • Education
    Journal of Medical Ethics
  • 2020
Based on an analysis of fair equality of opportunity in sport, a critical look is taken at the Semenya case and at IAAF’s DSD Regulations, providing conditional support of the Court of Arbitration for Sport (CAS) decision.

Impossible “Choices”: The Inherent Harms of Regulating Women’s Testosterone in Sport

The options forced by the new regulations are impossible choices, violate dignity, threaten privacy, and mete out both suspicion and judgement on the sex and gender identity of the athletes regulated.

The 2015 Pediatric Endocrine Society Ethics Symposium: Controversies Regarding ‘Gender Verification' of Elite Female Athletes - Sex Testing to Hyperandrogenism

An overview of the Pediatric Endocrine Society's Ethics Symposium held in April 2015 is provided by the panel moderators with a summary of efforts by international athletic governing bodies over several decades to ‘verify' the eligibility of athletes to compete in female only events, culminating in the hyperandrogenism policies that were the focus of the panel debate.

Natural Selection for Genetic Variants in Sport: The Role of Y Chromosome Genes in Elite Female Athletes with 46,XY DSD

Detailed evidence is presented here for the first time that genes for stature (and possibly other genes) on the Y chromosome are responsible for the increased frequency of 46,XY disorder of sex development among elite female athletes identified by eligibility tests.

Safeguarding in sports settings: unpacking a conflicting identity

ABSTRACT Safeguarding is a major area of research, policy, and practice for contemporary sports scholars, practitioners, and stakeholders. In recent years, the concept of safeguarding (broadly: the

On Loland’s conception of fair equality of opportunity in sport

In his latest paper, Loland tackles the question of whether athletes with differences of sexual development (DSD) may compete in the women’s division and recognises that some stable inequalities, such as biological sex and body size, are relevant to FEO in sport.

Preputial Hood Anomalies

World widely many women at different age groups, and at variable socioeconomic standers are not fully aware about the morphology, functions and anomalies of different parts of their genitalia. Many



Endocrine profiles in 693 elite athletes in the postcompetition setting

To measure a profile of hormones in a group of elite athletes. Increasing awareness of the widespread use of hormones as performance‐enhancing agents focusses attention on what may be considered as

Hyperandrogenism and intersex controversies in women's olympics.

An overview of past problems and an update of the newly adopted policies for eligibility for competition in women's events are provided.

Molecular diagnosis of 5α-reductase deficiency in 4 elite young female athletes through hormonal screening for hyperandrogenism.

5α-Reductase deficiency should be investigated in elite young female athletes with primary amenorrhea and high male T levels detected during antidoping programs to identify undiagnosed XY DSD.

Williams Textbook of endocrinology

Williams textbook of endocrinology / , Williams textbook of endocrinology / , کتابخانه دیجیتال جندی شاپور اهواز

Are the New Policies on Hyperandrogenism in Elite Female Athletes Really Out of Bounds? Response to “Out of Bounds? A Critique of the New Policies on Hyperandrogenism in Elite Female Athletes”

Over time, as women have had more opportunities to develop their talents, the differences in performance between male and female athletes have diminished, but it remains the case that on the elite level, few women would be rated among the 100 best men in most events.

289 Sex and Gender in Sport: Fallacy of the “Level Playing Field”

There is controversy regarding participation in high profile competitive events by female athletes perceived as inappropriately “masculine” by competitors and others. Over 50 years, international

Athletes Are Guinea Pigs

Three intertwined issues are called attention here to: the ubiquity of the “company doc” problem; the complex contextual features that render “autonomy versus paternalism” an inadequate framework for decision making by and for competitive athletes in team sports; and the environment of innovation and research that pervades team sports, in particular football.

Hirsutism and acne in polycystic ovary syndrome.

  • J. ArcherR. J. Chang
  • Medicine, Biology
    Best practice & research. Clinical obstetrics & gynaecology
  • 2004